Ruxolitinib-azide is a derivative of Ruxolitinib (R702000), which is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
Molecular Formula:C17H20N8
Molecular Weight:336.39
Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.